NRx Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2018 | $-473.2K | $-473.2K | — | — |
| FY2019 | $-792.7K | $-792.7K | — | — |
| FY2020 | $-2.3M | $-2.3M | $2.0K | $730.0K |
| FY2021 | $-37.7M | $-37.7M | $7.0K | $7.8M |
| FY2022 | $-39.8M | $-39.8M | $10.0K | $3.6M |
| FY2023 | $-21.7M | $-21.7M | $3.0K | $387.0K |
| FY2024 | $-10.6M | $-10.6M | $0 | $486.0K |
| FY2025 | $-14.1M | $-14.1M | — | $228.0K |